|
C17ORF39 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.218400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.043700E-04 |
| Normal-vs-Stage2 |
1.115980E-02 |
| Normal-vs-Stage3 |
3.219800E-02 |
| Normal-vs-Stage4 |
1.179560E-02 |
| Stage1-vs-Stage2 |
8.811000E-01 |
| Stage1-vs-Stage3 |
9.898800E-01 |
| Stage1-vs-Stage4 |
1.391210E-01 |
| Stage2-vs-Stage3 |
8.942400E-01 |
| Stage2-vs-Stage4 |
2.089600E-01 |
| Stage3-vs-Stage4 |
2.098000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.445200E-04 |
| Normal-vs-AfricanAmerican |
3.666300E-02 |
| Normal-vs-Asian |
5.342200E-02 |
| Caucasian-vs-AfricanAmerican |
4.153800E-01 |
| Caucasian-vs-Asian |
7.722200E-01 |
| AfricanAmerican-vs-Asian |
6.044000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.12969999999757E-05 |
| Normal-vs-Female |
4.014400E-01 |
| Male-vs-Female |
4.780900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.539500E-03 |
| Normal-vs-Extreme_Weight |
3.56070000000486E-05 |
| Normal-vs-Obese |
4.443800E-02 |
| Normal-vs-Extreme_Obese |
5.949600E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.941400E-01 |
| Normal_Weight-vs-Obese |
2.271600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.894800E-01 |
| Extreme_Weight-vs-Obese |
9.783900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.170800E-01 |
| Obese-vs-Extreme_Obese |
6.080400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.819900E-02 |
| Normal-vs-Age(41-60Yrs) |
9.676100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.63240999999648E-05 |
| Normal-vs-Age(81-100Yrs) |
7.95450000000697E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.024600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.833650E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.277600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.680800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.092300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.790160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.455540E-03 |
| Normal-VS-Type2 PRCC |
2.827400E-04 |
| Normal-VS-KIRP CIMP |
9.164900E-03 |
| Normal-VS-Unclassified PRCC |
7.239400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.541970E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.349200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.199200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.238000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.058300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.685610E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.22789999999784E-05 |
| Normal-vs-N1 |
2.764500E-02 |
| Normal-vs-N2 |
4.243500E-04 |
| N0-vs-N1 |
2.275600E-01 |
| N0-vs-N2 |
2.053600E-01 |
| N1-vs-N2 |
7.892200E-02 |
|
|
